Tag Archives: stats

Fewer Small Public Biotechs Today

Fig2-size-2008-vs-2013-115x76

A lot can happen in six years. The number of active biotech companies currently trading on US exchanges is now only 300. At the start of 2008, there were almost 400 active companies.   The net decrease in the number of active companies since 2008 is 24%. Had it not been for all the IPO activity we have seen this year, the decrease would have been substantially more. In fact, only 55% of the original Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Indices, IPOs, Approvals – YTD Update Aug 14th, 2012

We are now more than eight months into the year and biotech indices have maintained their outperformance, squeezed out a modest size IPO class, and delivered double digit novel FDA approvals. 1. Indices. The Nasdaq Biotech Index (NBI) is up 27% Year to Date (YTD) as of last Friday. It was up nearly 20% by the end of the 1st quarter, consolidated during the 2nd quarter, and has participated in the summer rally to tack on another 7%. Here Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Partnering Milestones

In case you couldn’t tell, we’re really excited about the BIO Business Forum this year.  As mentioned in an earlier post, we opened BIO One-on-One Partnering earlier than expected to accommodate the level of interest we were seeing.  And we’re pleased to see that that interest has not been slowing down.  How much so? We have over 2,300 business development professionals – from around the world – already registered. We’re up to 3,000+ number of Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Asia partnering is heating up!

Less than a week to go until the 7th Annual BIO Asia International Partnering Conference and it is clear that we are on pace to beat the number of total partnering meetings done from last year. Check out the little snippet from Google analytics to the right.  This past Monday represented the highest day of activity within the system to date! In 2008, we had a total of 693 partnering meetings scheduled at the conference Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,

1 in 4 Biotechs Above 100% – Waterfall Chart YTD

Year to date,  27% of biotech stocks have doubled in price. 65% are in positive territory in 2009, a strong contrast to the YTD data last year:

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,